BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23196585)

  • 41. Laboratory abnormalities in patients with myotonic dystrophy type 2.
    Heatwole C; Johnson N; Goldberg B; Martens W; Moxley R
    Arch Neurol; 2011 Sep; 68(9):1180-4. PubMed ID: 21911698
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myotonic dystrophies type 1 and 2: anesthetic care.
    Veyckemans F; Scholtes JL
    Paediatr Anaesth; 2013 Sep; 23(9):794-803. PubMed ID: 23384336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Greek National Cross-Sectional Study on Myotonic Dystrophies.
    Papadimas GK; Papadopoulos C; Kekou K; Kartanou C; Kladi A; Nitsa E; Sofocleous C; Tsanou E; Sarmas I; Kaninia S; Chroni E; Tsivgoulis G; Kimiskidis V; Arnaoutoglou M; Stefanis L; Panas M; Koutsis G; Karadima G; Traeger-Synodinos J
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism.
    Meola G; Cardani R
    J Neuromuscul Dis; 2015 Jul; 2(s2):S59-S71. PubMed ID: 27858759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epigenetics of Myotonic Dystrophies: A Minireview.
    Visconti VV; Centofanti F; Fittipaldi S; Macrì E; Novelli G; Botta A
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proximal myotonic myopathy: clinical and molecular investigation of a Norwegian family with PROMM.
    Sun C; Henriksen OA; Tranebjaerg L
    Clin Genet; 1999 Dec; 56(6):457-61. PubMed ID: 10665666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation of sensitivity and specificity of tetraplet-primed PCR (TP-PCR) in the molecular diagnosis of myotonic dystrophy type 2 (DM2).
    Catalli C; Morgante A; Iraci R; Rinaldi F; Botta A; Novelli G
    J Mol Diagn; 2010 Sep; 12(5):601-6. PubMed ID: 20616365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Myotonic dystrophy].
    Nanba E
    Nihon Rinsho; 2005 Mar; 63(3):429-33. PubMed ID: 15773341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Absence of a differentiation defect in muscle satellite cells from DM2 patients.
    Pelletier R; Hamel F; Beaulieu D; Patry L; Haineault C; Tarnopolsky M; Schoser B; Puymirat J
    Neurobiol Dis; 2009 Oct; 36(1):181-90. PubMed ID: 19632331
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proximal myotonic myopathy: a syndrome with a favourable prognosis?
    Meola G; Sansone V; Marinou K; Cotelli M; Moxley RT; Thornton CA; De Ambroggi L
    J Neurol Sci; 2002 Jan; 193(2):89-96. PubMed ID: 11790388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myotonic disorders.
    Mankodi A
    Neurol India; 2008; 56(3):298-304. PubMed ID: 18974556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms.
    Meola G; Cardani R
    Biochim Biophys Acta; 2015 Apr; 1852(4):594-606. PubMed ID: 24882752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A role for PLCβ1 in myotonic dystrophies type 1 and 2.
    Faenza I; Blalock W; Bavelloni A; Schoser B; Fiume R; Pacella S; Piazzi M; D'Angelo A; Cocco L
    FASEB J; 2012 Jul; 26(7):3042-8. PubMed ID: 22459146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2.
    Vihola A; Bassez G; Meola G; Zhang S; Haapasalo H; Paetau A; Mancinelli E; Rouche A; Hogrel JY; Laforêt P; Maisonobe T; Pellissier JF; Krahe R; Eymard B; Udd B
    Neurology; 2003 Jun; 60(11):1854-7. PubMed ID: 12796551
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and molecular aspects of the myotonic dystrophies: a review.
    Machuca-Tzili L; Brook D; Hilton-Jones D
    Muscle Nerve; 2005 Jul; 32(1):1-18. PubMed ID: 15770660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Type 2 myotonic dystrophy can be predicted by the combination of type 2 muscle fiber central nucleation and scattered atrophy.
    Bassez G; Chapoy E; Bastuji-Garin S; Radvanyi-Hoffman H; Authier FJ; Pellissier JF; Eymard B; Gherardi RK
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):319-25. PubMed ID: 18379436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Skeletal muscle involvement in myotonic dystrophy type 2. A comparative muscle ultrasound study.
    Tieleman AA; Vinke A; van Alfen N; van Dijk JP; Pillen S; van Engelen BG
    Neuromuscul Disord; 2012 Jun; 22(6):492-9. PubMed ID: 22414627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New classification and treatment for myotonic disorders.
    Kurihara T
    Intern Med; 2005 Oct; 44(10):1027-32. PubMed ID: 16293911
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proximal myotonic myopathy: clinical, electrophysiological and pathological findings in a family.
    Kohler A; Burkhard P; Hefft S; Bottani A; Pizzolato GP; Magistris MR
    Eur Neurol; 2000; 43(1):50-3. PubMed ID: 10601809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebral involvement in myotonic dystrophies.
    Meola G; Sansone V
    Muscle Nerve; 2007 Sep; 36(3):294-306. PubMed ID: 17486579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.